神鳥 周也(カンドリ シュウヤ)

研究者情報全体を表示

論文

• Pembrolizumab monotherapy for high-risk non-muscleinvasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial
  Necchi Andrea; Roumiguie Mathieu; Kamat Ashish M.; Sho...
  LANCET ONCOLOGY/25(6)/pp.720-730, 2024-06
• TNFSF9 Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and Ipilimumab
  Isoda Bunpei; Kandori Shuya; Sazuka Tomokazu; Kojima ...
  INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES/25(13), 2024-07
• 骨盤内手術術後大腿神経麻痺を来たした2例
  木名瀬 聡華; 星 昭夫; 飯村 翼; 櫻井 浩成; 磯田 文平; 古城 公佑; 目 翔太郎; 田中...
  泌尿器科紀要/61(1)/pp.25-28, 2023-01
• 院内がん登録を用いた本邦の陰茎SCCおよび乳房パジェット病患者の予後解析
  神鳥 周也; 佐野 啓介; 田沼 光三郎; 目 翔太郎; 新田 聡; 千原 尉智蕗; 古城 公佑; ...
  日本癌治療学会学術集会抄録集61回, 2023-10
• Combination Chemotherapy With TS-1 and Cisplatin for Urinary Adenocarcinoma: A Retrospective Case Series
  Omiya Akifumi; Nitta Satoshi; Kandori Shuya; Takahashi...
  Clinical genitourinary cancer/22(5), 2024-07-03
  
  PubMed
• Retroperitoneal sarcoma: a 10-year follow-up analysis using hospital-based cancer registry data in Japan
  Nitta Satoshi; Kandori Shuya; Takahashi Reo; Suzuki S...
  JAPANESE JOURNAL OF CLINICAL ONCOLOGY/54(6)/pp.716-721, 2024-06-01
• Adult genitourinary sarcoma: analysis using hospital-based cancer registry data in Japan
  Nitta Satoshi; Kandori Shuya; Kojo Kosuke; Suzuki Shu...
  BMC CANCER/24(1), 2024-02-15
• A new clustering model based on the seminal plasma/serum ratios of multiple trace element concentrations in male patients with subfertility
  Tanaka Takazo; Kojo Kosuke; Nagumo Yoshiyuki; Ikeda A...
  Reproductive medicine and biology/23(1), 2024-04-01
  
  PubMed
• Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy
  Matsushita Yuto; Kojima Takahiro; Osawa Takahiro; Sazu...
  INTERNATIONAL JOURNAL OF UROLOGY/31(5)/pp.526-533, 2024-05
• 回腸導管造設術後にストーマ周囲静脈瘤から出血を来たした２例
  山﨑琢斗; 吉野喬之; 古城公佑; 木村友和; 松田琴絵; 磯田文平; 田中隆造; 土屋春樹; 志賀正宣; 南雲義...
  泌尿器科紀要/70(4)/pp.101-106, 2024-04
• Complete Response to Enfortumab Vedotin in a Hemodialysis Patient with Metastatic Urothelial Carcinoma: A Case Report
  Isoda Bunpei; Shiga Masanobu; Kandori Shuya; Nagumo Y...
  CASE REPORTS IN ONCOLOGY/16(1)/pp.429-433, 2023-04-01
  
  PubMed
• Glycoprotein nonmetastatic melanoma protein B impacts the malignant potential of bladder cancer cells through its hem-immunoreceptor tyrosine-based activation motif
  Kimura Tomokazu; Okita Yukari; Nagumo Yoshiyuki; Chin ...
  PATHOLOGY INTERNATIONAL/74(5)/pp.262-273, 2024-03-19
  
  PubMed
• A Machine Learning Model to Predict the Histology of Retroperitoneal Lymph Node Dissection Specimens
  Nitta Satoshi; Kojima Takahiro; Gido Masanobu; Nakagaw...
  Anticancer research/44(5)/pp.2151-2157, 2024-05-01
  
  PubMed
• Patient characteristics correlate with diagnostic performance of photodynamic diagnostic assisted transurethral resection of bladder tumors: A retrospective, single-center study
  Suzuki Shuhei; Nagumo Yoshiyuki; Ikeda Atsushi; Kojo ...
  PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY/46, 2024-03-18
  
  PubMed
• Objective evaluation of gaze location patterns using eye tracking during cystoscopy and artificial intelligence-assisted lesion detection
  Ikeda Atsushi; Izumi Kazuya; Katori Kensuke; Nosato H...
  Journal of endourology/Epub, 2024-03-25
  
  PubMed
• The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan
  Suzuki Shuhei; Nagumo Yoshiyuki; Kandori Shuya; Kojo ...
  INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/29(3)/pp.318-324, 2024-01-24
  
  PubMed
• Pembrolizumab (pembro) monotherapy for patients (pts) with high-risk non-muscleinvasive bladder cancer (HR NMIBC) unresponsive to bacillus Calmette-Gu ′erin (BCG): Results from cohort B of the phase 2 KEYNOTE-057 trial.
  Necchi Andrea; Roumiguie Mathieu; Esen Ahmet Adil; Leb...
  JOURNAL OF CLINICAL ONCOLOGY/41(6), 2023-02-20
• The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database
  Koguchi Tomoyuki; Naito Sei; Hatakeyama Shingo; Numaku...
  CANCER MEDICINE/Epub, 2023-10-31
• Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study Group
  Horie Shigemitsu; Naito Sei; Hatakeyama Shingo; Kandor...
  INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/28(11:SI)/pp.1538-1544, 2023-11
• Variant allele frequency changes in TP53 predict pembrolizumab response in patients with metastatic urothelial carcinoma
  Hamada Kazuki; Nagumo Yoshiyuki; Kandori Shuya; Tanuma...
  ONCOLOGY LETTERS/26(3), 2023-09
• Tolerability of immune checkpoint inhibitor doublet for advanced renal cell carcinoma patients with pre-dialysis chronic kidney disease or end-stage renal disease
  Kandori Shuya
  INTERNATIONAL JOURNAL OF UROLOGY/Epub, 2023-07-11
• ロボット支援腹腔鏡下前立腺全摘除術後の大腿ヘルニアを生じた1例
  池田 篤史; 宮川 友明; 黒部 匡広; 神鳥 周也; 堤 雅一; 丸山 常彦
  泌尿器外科/27(6)/pp.1035-1035, 2014-06-15
• ロボット支援腹腔鏡下前立腺全摘除術後に大腿ヘルニアを生じた1例
  池田 篤史; 宮川 友明; 黒部 匡広; 神鳥 周也; 堤 雅一; 丸山 常彦
  茨城県臨床医学雑誌/(50)/pp.94-95, 2015-03
• Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi‑institutional retrospective study
  Kato Renpei; Naito Sei; Numakura Kazuyuki; Hatakeyama Sh...
  International journal of clinical oncology/28(5)/pp.726-727, 2023-05-01
  
  PubMed
• Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi‑institutional retrospective study
  Kato Renpei; Naito Sei; Numakura Kazuyuki; Hatakeyama ...
  International journal of clinical oncology/28(5)/pp.726-727, 2023-05-01
  
  PubMed
• さらに表示...